Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Therapeutics and Clinical Risk Management


Archive: Volume 15, 2019

New therapies for the treatment of heart failure: a summary of recent accomplishments

Machaj F, Dembowska E, Rosik J, Szostak B, Mazurek-Mochol M, Pawlik A

Therapeutics and Clinical Risk Management 2019, 15:147-155

Published Date: 22 January 2019

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study

Huang CH, Lai YY, Kuo YJ, Yang SC, Chang YJ, Chang KK, Chen WK

Therapeutics and Clinical Risk Management 2019, 15:103-112

Published Date: 10 January 2019

Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study

Chen Z, Hu B, Feng Y, Wang Z, Jiang X, Cheng Y, He D, Zhu D, Xiao Z, Wang H, Mao Z

Therapeutics and Clinical Risk Management 2019, 15:65-72

Published Date: 28 December 2018

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database

Inada A, Hosohata K, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K

Therapeutics and Clinical Risk Management 2019, 15:59-64

Published Date: 24 December 2018

Is correction of segmental kyphosis necessary in single-level anterior cervical fusion surgery? An observational study

Lu J, Sun C, Bai J, Tian S, Zhang B, Tian D, Kong L

Therapeutics and Clinical Risk Management 2019, 15:39-44

Published Date: 19 December 2018

Sex differences in clinical characteristics and 1-year outcomes of young ischemic stroke patients in East China

Geng C, Lin Y, Tang Q, Tang Y, Wang X, Zhou JS, Yang J, Zheng D, Zhang YD

Therapeutics and Clinical Risk Management 2019, 15:33-38

Published Date: 19 December 2018